FDA Clearance Tracker · P910073-S187
ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leads
Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 6, 2026
Approved
Time to decision
37 days
Received Jan 28, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P910073-S187
- Device name
- ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leads
- Applicant
- Boston Scientific
- Applicant location
- St Paul, MN
- Received
- Jan 28, 2026
- Decided
- Mar 6, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P910073
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for the related transfer of the downstream final packaging process from the Boston Scientific Puerto Rico Dorado site to Boston Scientific Quincy, Massachusetts facility to enable regionally co-located operations for the CRM leads.
Source documents
Other decisions for Boston Scientific
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
- Rezum System510(k)
K262460 · Decided Sep 3, 2026 · 48 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
K261153 · Decided Aug 26, 2026 · 140 days after receipt
Device type: Ureteroscope And Accessories, Flexible/Rigid (FGB) · GI, Urology & Nephrology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.